You are here

  • Home
  • Archive
  • Volume 13, Issue 8
  • Development of a risk prediction tool for patients with locally advanced and recurrent rectal cancer undergoing pelvic exenteration: protocol for a mixed-methods study

Article info

Article menu
Surgery
Protocol
Development of a risk prediction tool for patients with locally advanced and recurrent rectal cancer undergoing pelvic exenteration: protocol for a mixed-methods study

Authors

  • Kilian Brown Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaSurgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaInstitute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Michael Solomon Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaSurgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaInstitute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Kheng-Seong Ng Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaSurgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaInstitute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Colorectal Surgery, Concord Repatriation General Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Paul Sutton Colorectal & Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, UKDivision of Cancer Sciences, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Cherry Koh Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaSurgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaInstitute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Kate White Sydney Nursing School, University of Sydney, Sydney, New South Wales, AustraliaThe Daffodil Centre, University of Sydney and Cancer Council NSW, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Daniel Steffens Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • EviSurg Research Group
    Google scholar articles
  1. Correspondence to Dr Kilian Brown; kilian.brown{at}sydney.edu.au
View Full Text

Citation

Brown K, Solomon M, Ng K, et al
Development of a risk prediction tool for patients with locally advanced and recurrent rectal cancer undergoing pelvic exenteration: protocol for a mixed-methods study
BMJ Open 2023;13:e075304. doi: 10.1136/bmjopen-2023-075304

Publication history

  • Received May 4, 2023
  • Accepted August 18, 2023
  • First published August 30, 2023.
Online issue publication 
August 30, 2023
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.